Ascendis Pharma
Ascendis Pharma sells approved medicines and develops others using its TransCon technology platform applied to clinically validated parent drugs, work that places it in the endocrinology and rare-disease peptides layer.
Revised after a check against the company's own annual filing.
Latest disclosed
20-F filed 2026-02-11 · period ending 2025-12-31
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.